Ashil Koranne presented a poster at the 2024 MDA Clinical & Scientific Conference highlighting Juvena Therapeutics’ promising preclinical development of JUV-161, a novel fusion protein for treating Myotonic Dystrophy Type 1.
Dr. Hanadie Yousef attends the Global Healthspan Summit in Riyadh, Saudi Arabia, organized by the Hevolution Summit as an invited speaker showcased on their Entrepreneurship Spotlight panel
